AML: Using Available Evidence and Guidelines to Make Sense of a Rapidly Evolving Treatment Paradigm

Get up to date on optimal use of new agents and approaches in the care of your patients with AML with downloadable slides from a live Webinar, along with a clinical resource.
Amir Fathi, MD
Alice Mims, MD, MSCR
Farhad Ravandi, MD

Clinical Resource

Download this CCO/NCCN PDF guide to best practices for the management of patients with acute myeloid leukemia.

Released: December 4, 2020

Downloadable Slidesets

Download these expert-selected slides on optimal treatment of patients with newly diagnosed AML without actionable mutations.

Alice Mims, MD, MSCR Released: December 4, 2020

Download these expert-selected slides on optimal treatment of patients with newly diagnosed AML with actionable mutations.

Amir Fathi, MD Released: December 4, 2020

Download these expert-selected slides on optimal treatment of patients with AML with maintenance therapy, MRD testing, and clinical trials.

Farhad Ravandi, MD Released: December 4, 2020

Download this short summary slideset of key takeaways from a CCO Live Webinar for curated overview of current guidelines and optimal treatment of patients with AML in the clinic today.

Released: December 17, 2020
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC.

Produced in collaboration with
NCCN Logo

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0239
215-690-0283 (Fax)
education@nccn.org
For Clinicians:
NCCN.org
For Patients:
NCCN.org/patients

Supported by educational grants from
Agios Pharmaceuticals
Jazz Pharmaceuticals, Inc.
Pfizer Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue